APOA1 and Cognitive impairment: Some studies [Experimental Animal Study, N = 63] indicate that elevated CSF ApoA-I levels correlate with slower cognitive decline in individuals with mild cognitive impairment, suggesting a possible compensatory or neuroprotective role within the CNS [122,123].